| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |